Jing Zhang

Jing Zhang

Auto-generated profile, based on publicly available information

Jing Zhang

Department of Radiology, The First Affiliated Hospital of Nanjing Medical University; Nanjing, Jiangsu Province, PR China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications



1 June 2021 in EBioMedicine
Verified
Journal Article
Open access
YHYing Hou
Ying Hou
JBJie Bao
Jie Bao
YSYang Song
Yang Song
MBMei-Ling Bao
Mei-Ling Bao
KJKe-Wen Jiang
Ke-Wen Jiang
YZYu-Dong Zhang
Yu-Dong Zhang
Accurate identification of pelvic lymph node metastasis (PLNM) in patients with prostate cancer (PCa) is crucial for determining appropriate treatment options. Here, we built a PLNM-Risk calculator to obtain a precisely informed decision about whether to perform extended pelvic lymph node dissection (ePLND). The PLNM-Risk calculator was developed in 280 patients and verified internally in 71 patients and externally in 50 patients by integrating a set of radiologists' interpretations, clinicopathological factors and newly refined imaging indicators from MR images with radiomics machine learning and deep transfer learning algorithms. Its clinical applicability was compared with Briganti and Memorial Sloan Kettering Cancer Center (MSKCC) nomograms. The PLNM-Risk achieved good diagnostic discrimination with areas under the receiver operating characteristic curve (AUCs) of 0.93 (95% CI, 0.90-0.96), 0.92 (95% CI, 0.84-0.97) and 0.76 (95% CI, 0.62-0.87) in the training/validation, internal test and external test cohorts, respectively. If the number of ePLNDs missed was controlled at < 2%, PLNM-Risk provided both a higher number of ePLNDs spared (PLNM-Risk 59.6% vs MSKCC 44.9% vs Briganti 38.9%) and a lower number of false positives (PLNM-Risk 59.3% vs MSKCC 70.1% and Briganti 72.7%). In follow-up, patients stratified by the PLNM-Risk calculator showed significantly different biochemical recurrence rates after surgery. The PLNM-Risk calculator offers a noninvasive clinical biomarker to predict PLNM for patients with PCa. It shows improved accuracy of diagnosis support and reduced overtreatment burdens for patients with findings suggestive of PCa. This work was supported by the Key Research and Development Program of Jiangsu Province (BE2017756) and the Suzhou Science and Technology Bureau-Science and Technology Demonstration Project (SS201808).


1 October 2015 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
YZYu-Dong Zhang
Yu-Dong Zhang
CWChen-Jiang Wu
Chen-Jiang Wu
JZJing Zhang
Jing Zhang
XWXiao-Ning Wang
Xiao-Ning Wang
XLXisheng Liu
Xisheng Liu
HSHai-Bin Shi
Hai-Bin Shi